Why Do You Have To Be Careful With TransEnterix Stock

TransEnterix

Why Do You Have To Be Careful With TransEnterix Stock – CWEB.com
TransEnterix, (TRXC) Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery.
According to recent studies Robotic assisted minimally invasive surgery does not appear to offer any clinical benefits over conventional laparoscopic techniques in terms of outcomes and complication rates but is associated with significantly higher costs, two new studies of cancers indicate.
TransEnterix surgical bot, Senhance, only does laparoscopic surgery.

The Senhance is an old surgical robot, approved in Europe in 2011, and only three have been sold by TransEnterix in Europe.

This report will likely have negative implications for TransEnterix financial top and bottom lines.

[youtube https://www.youtube.com/watch?v=9TXBP1t2rUc&w=560&h=315]

According to a recent wall street research:

It is difficult to establish if TransEnterix has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
It is difficult to establish if TransEnterix has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.
It is difficult to establish if TransEnterix improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
There’s no way TransEnterix will build a business worthy of today’s nearly $500 million stock market valuation. We believe the company, which has accumulated over $333 million in losses, would be overpriced at a price-to-sales less than a fifth of the current 94 ratio.

CWEB Analysts have issued a Hold Rating for TransEnterix, (TRXC) Inc.

Read Full Article and Videos CWEB.com – Trending News, Blog, Shopping

Chart
TRXC data by YCharts


Follow us on Google news for more updates and News










PLEASE READ THE IMPORTANT DISCLOSURES BELOW.

This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with CWEB Inc, a business. This content and any information contained therein, does not constitute a recommendation by CWEB to buy, sell or hold any security, financial product or instrument referenced in the content. This information neither is, nor should be construed as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. CWEB Inc. does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Unless stated otherwise, the web content provided by the CWEB family of companies is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by CWEB Inc. or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.

Full Disclaimer

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.